More recent studies by a retrospective cohort study suggest that the imbalance between cytotoxic and regulatory T lymphocytes(CD8+/Foxp3 T lymphocyte ratio) in the peri-tumoral PTC/HT(-) may affect the tumor-specific immune response. The gene discussed is FOXP3; the disease is neoplasm.